Agricultural Opportunities
Executive Summary
Millennium's recent blockbuster deal with Monsanto isn't in healthcare--it's in agriculture. Now other drug-oriented biotechs are considering whether they too can leverage their discovery assets this way. Some firms believe their technologies are directly translatable; others say ag companies can't afford to pay for the methods. The big question: whether to do exclusive deals.